4.4 Review

Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer

期刊

PATHOBIOLOGY
卷 82, 期 3-4, 页码 113-123

出版社

KARGER
DOI: 10.1159/000433583

关键词

Breast carcinoma; Epigenetics; Epithelial-mesenchymal transition; Extracellular matrix; Invasion; Lymphangiogenesis; Lymphovascular invasion; Migration; Tumorigenesis

资金

  1. National Institute for Health Research [ACF-2009-12-003, CL-2010-12-003] Funding Source: researchfish

向作者/读者索取更多资源

Lymphovascular invasion (LVI), the presence of malignant cells within lymphovascular channels, is a crucial step in the invasion-metastasis cascade. LVI, when identified morphologically in the peritumoural area, is regarded as an indicator of metastatic potential and is strongly associated with a poor prognosis in many solid tumours, including breast cancer (BC). Although molecular mechanisms associated with the development of LVI have been extensively studied, details of driver genes, and molecular pathways and mechanisms involved in its development in BC, remain poorly defined. Although invasive BC cells have the ability to invade surrounding stroma, only those that can interact with endothelial cells, penetrate the vascular wall and withstand the intravascular stress will develop LVI and complete metastatic dissemination. Identification of additional molecular events associated with LVI in the primary tumour and characterisation of the contribution of the tumour micro-environment to modulating biological processes leading to LVI in BC remain a challenging task. This stems not only from the complexity of the molecular alterations in the primary tumour and the interactions with different components of its micro-environment but also from the subjective nature of LVI assessment in human BC. In this review, we discuss the clinicopathological features and the current knowledge of the molecular mechanisms underlying LVI in BC. (C) 2015 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据